Martin Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.95M Sell
46,280
-738
-2% -$86.4K 1.99% 21
2026
Q1
$5.66M Buy
47,018
+788
+2% +$91K 1.69% 22
2025
Q4
$4.87M Sell
46,230
-3,123
-6% -$293K 1.36% 27
2025
Q3
$4.14M Sell
49,353
-1,123
-2% -$92.5K 1.05% 30
2025
Q2
$4M Buy
50,476
+385
+0.8% +$30.6K 1.02% 29
2025
Q1
$4.5M Sell
50,091
-49
-0.1% -$4.58K 1.13% 29
2024
Q4
$4.99M Buy
50,140
+458
+0.9% +$47.2K 1.37% 27
2024
Q3
$5.64M Buy
49,682
+2,900
+6% +$345K 1.38% 28
2024
Q2
$5.79M Sell
46,782
-1,556
-3% -$200K 1.49% 28
2024
Q1
$6.38M Buy
48,338
+68
+0.1% +$8.38K 1.57% 25
2023
Q4
$5.26M Sell
48,270
-486
-1% -$50.4K 1.57% 27
2023
Q3
$5.02M Sell
48,756
-728
-1% -$78.5K 1.5% 27
2023
Q2
$5.71M Buy
+49,484
New +$5.62M 1.61% 27

Other funds holding MRK

Martin Investment Management's MRK Position: Q2 2026 in Review

Martin Investment Management reduced its Merck (MRK) stake by 1.6% in Q2 2026, selling an estimated $86.4K and leaving 46,280 shares worth $5.95M. The position accounts for 1.99% of the portfolio, ranked #21.

Martin Investment Management first reported a position in MRK in Q2 2023 and has held it in 13 quarters since. The position peaked at $6.38M in Q1 2024. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Martin Investment Management held 46,280 shares of Merck worth $5.95M as of Q2 2026.
  • Martin Investment Management sold 738 Merck shares in Q2 2026, an estimated $86.4K.
  • Merck made up 1.99% of Martin Investment Management's portfolio in Q2 2026, its #21 holding.
  • Martin Investment Management first reported a position in Merck in Q2 2023 and has held it in 13 quarters since.
  • Martin Investment Management's Merck position peaked at $6.38M in Q1 2024.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Martin Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.